Zobrazeno 1 - 10
of 185
pro vyhledávání: '"Catherine M. Kelly"'
Autor:
Lynda M. McSorley, Mehala Tharmabala, Fathiya Al Rahbi, Fergus Keane, Denis Evoy, James G. Geraghty, Jane Rothwell, Damian P. McCartan, Megan Greally, Miriam O’Connor, Deirdre O’Mahony, Maccon Keane, Michael John Kennedy, Seamus O’Reilly, Steve J. Millen, John P. Crown, Catherine M. Kelly, Ruth S. Prichard, Cecily M. Quinn, Janice M. Walshe
Publikováno v:
Current Oncology, Vol 31, Iss 3, Pp 1302-1310 (2024)
Background: This study, using real-world data, assesses the impact of RS testing on treatment pathways and the associated economic consequences of such testing. This paper pertains to lobular breast cancer. Methods: A retrospective, observational stu
Externí odkaz:
https://doaj.org/article/c7e991104cdb4851bf2dfdfc09b20e5d
Autor:
Fionán Donohoe, Yvonne O’Meara, Aidin Roberts, Louise Comerford, Ivaila Valcheva, Una Kearns, Marie Galligan, Michaela J. Higgins, Alasdair L. Henry, Catherine M. Kelly, Janice M. Walshe, Martha Hickey, Donal J. Brennan
Publikováno v:
Cancers, Vol 16, Iss 6, p 1127 (2024)
Background: Vasomotor symptoms (VMSs) associated with menopause represent a significant challenge for many patients after cancer treatment, particularly if conventional menopausal hormone therapy (MHT) is contraindicated. Methods: The Menopause after
Externí odkaz:
https://doaj.org/article/7fc676ad7bc142d4842c5f7424a7718b
Autor:
Katya Galactionova, Sibylle Loibl, Paola Salari, Frederik Marmé, Miguel Martin, Michael Untch, Hervé R. Bonnefoi, Sung-Bae Kim, Harry D. Bear, Nicole McCarthy, Karen A. Gelmon, José A. García-Sáenz, Catherine M. Kelly, Toralf Reimer, Masakazu Toi, Hope S. Rugo, Michael Gnant, Andreas Makris, Nicole Burchardi, Matthias Schwenkglenks
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundPatients with hormone receptor-positive, HER2-negative breast cancer who have residual invasive disease after neoadjuvant chemotherapy (NACT) are at a high risk of relapse. PENELOPE-B was a double-blind, placebo-controlled, phase III trial
Externí odkaz:
https://doaj.org/article/309493d924a94d99901b52801051e924
Autor:
Lisa Prior, Hannah Featherstone, David O’Reilly, Killian Nugent, Marvin Lim, John McCaffrey, Michaela J Higgins, Catherine M. Kelly
Publikováno v:
Cardio-Oncology, Vol 7, Iss 1, Pp 1-9 (2021)
Abstract Background Due to advances in care, most women diagnosed with breast cancer do not die from the disease itself. Instead, cardiovascular disease (CVD) remains the most frequent cause of death. Many breast cancer patients are older and have es
Externí odkaz:
https://doaj.org/article/9e8b320586f647c98c4f41c4871d326d
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-36 (2020)
Abstract Background Breast cancer care today involves state-of-the-art biomedical treatment but can fail to address the broader psychosocial and quality-of-life (QoL) issues associated with the transition to breast cancer survivorship. This scoping r
Externí odkaz:
https://doaj.org/article/79df9d987f3c433a8a7fd39b7dcf9de3
Autor:
Fionán Donohoe, Yvonne O'Meara, Aidin Roberts, Louise Comerford, Catherine M. Kelly, Janice M. Walshe, Michelle Peate, Martha Hickey, Donal J. Brennan
Publikováno v:
Contemporary Clinical Trials Communications, Vol 24, Iss , Pp 100865- (2021)
Aims: This study will aim to assess if a composite intervention which involves a specific evidence-based intervention for management of insomnia and non-hormonal pharmacotherapy to manage vasomotor symptoms (VMS) of menopause can improve quality of l
Externí odkaz:
https://doaj.org/article/921b7a89bb2646ac8d51b7c7875e52c9
Autor:
Niamh M. Keegan, Simon J. Furney, Janice M. Walshe, Giuseppe Gullo, M. John Kennedy, Diarmuid Smith, John McCaffrey, Catherine M. Kelly, Keith Egan, Jennifer Kerr, Mark Given, Peter O’Donovan, Andres Hernando, Ausra Teiserskiene, Imelda Parker, Elaine Kay, Angela Farrelly, Aoife Carr, Giulio Calzaferri, Ray McDermott, Maccon M. Keane, Liam Grogan, Oscar Breathnach, Patrick G. Morris, Sinead Toomey, Bryan T. Hennessy
Publikováno v:
Cancers, Vol 13, Iss 6, p 1225 (2021)
Background: Activation of the phosphoinositide-3 kinase (PI3K) pathway is a resistance mechanism to anti-human epidermal growth factor receptor 2 (HER2) therapy. This phase Ib trial was conducted to determine the maximum tolerated dose (MTD) of copan
Externí odkaz:
https://doaj.org/article/866b588805c44d53b259bc41e6f9fa7e
Autor:
Cathriona Kearns, Ronan Feighery, John Mc Caffrey, Michaela Higgins, Martina Smith, Verena Murphy, Seamus O’Reilly, Anne M. Horgan, Janice Walshe, Ray McDermott, Patrick G. Morris, Maccon Keane, Michael Martin, Conleth Murphy, Karen Duffy, Alina Mihai, John Armstrong, Dearbhaile M. O’Donnell, William M. Gallagher, Ciara M. Kelly, Catherine M. Kelly
Publikováno v:
Cancers, Vol 12, Iss 7, p 1921 (2020)
Cancer clinical trials (CCTs) are critical to translation and development of better therapies to improve outcomes. CCTs require adequate patient involvement but accrual rates are low globally. Several known barriers impede participation and knowing h
Externí odkaz:
https://doaj.org/article/52d649ccd941494ea8cb23ce2d8e8a12
Autor:
Danielle B. Zakon, Coralie Poncet, Fatima Cardoso, Neven Anouk, Vicente Valero, Stefan Aebi, Kim Benstead, Oliver Bogler, Lissandra Dal Lago, Judith Fraser, Carmela Caballero, Ingrid A. Hedenfalk, Larissa A. Korde, Barbro Linderholm, John WM Martens, Lavinia P. Middleton, Melissa Murray, Catherine M. Kelly, Cecilia Nilsson, Monika Nowaczyk, Stephanie Peeters, Melanie Beauvois, Peggy Porter, Carolien P. Schroder, Isabel T. Rubio, Kathryn Ruddy, Christi van Asperen, Danielle Van Den Weyngaert, Carolien HM van Deurzen, Elise van Leeuwen-Stok, Joanna M. Vermeij, John MS Bartlett, Antonio C. Wolff, Sharon H. Giordano, W. Fraser Symmans
Publikováno v:
Cancer Research. 83:PD6-11
Introduction Breast cancer is uncommon in men. Almost all male breast cancers are hormone receptor-positive, HER2-negative, although the pathogenesis is not always attributable to an endocrine condition. A few studies have compared biological charact
Autor:
Carsten Denkert, Miguel Martín, Michael Untch, Hervé R. Bonnefoi, Erik S. Knudsen, Seock-Ah Im, Angela DeMichele, Agnieszka Witkiewicz, Laura Van ’t Veer, Sung-Bae Kim, Harry D. Bear, Nicole McCarthy, Karen Gelmon, Frederik Marmé, José Ángel García-Sáenz, Nicholas Turner, Federico Rojo, Martin Filipits, Lesley-Ann Martin, Peter A. Fasching, Christian Schem, Catherine M. Kelly, Toralf Reimer, Masakazu Toi, Hope Rugo, Michael Gnant, Andreas Makris, Yuan Liu, Karsten Weber, Sivaramakrishna Rachakonda, Sibylle Loibl
Publikováno v:
Cancer Research. 83:HER2-06
Background: Breast cancer with low HER2 expression (HER2-low) is of high clinical relevance because of new therapeutic options with antibody-drug conjugates. We have recently shown in a large cohort from neoadjuvant clinical trials that HER2-low brea